Patent · US Active

Drug delivery system and method for the treatment of neuro-degenerative disease

US9034347B2 · kind B2 · utility

4Cited by

0References

5Claims

0Family size

Assignees

Arphios Corporation · US
For the Board of Supervisors of Louisiana State University and Agricultural and Mechanical College acting on behalf of Louisiana State University Health Sciences Center at Shreveport · US

Inventors

Trevor Percival Castor · Arlington, US
Jonathan Alexander · Roswell, US
Geoffrey Purdum · Hillsborough Township, US
J. David Rios · Burlington, US
Lisa M. Schrott · Decatur, US
Theodore A. Tyler · Framingham, US
Maria I. Vizcaino · New Haven, US

Key dates

Filing date	Dec 19, 2012
Grant date	May 19, 2015
Priority date	—
Expiry date	Apr 26, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/365
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Embodiments of the present invention are directed to the oral administration of Bryostatins for the treatment of neuro-degenerative disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.